Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nifuratel (CAS 4936-47-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
5-[(Methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-2-oxazolidinone
Application:
Nifuratel is an antibacterial, antifungal, and antiprotozoal compound
CAS Number:
4936-47-4
Molecular Weight:
285.28
Molecular Formula:
C10H11N3O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Nifuratel, with the CAS number 4936-47-4, is a nitrofuran derivative recognized for its broad antimicrobial properties, targeting a variety of pathogens including bacteria, fungi, and protozoa. The compound′s mechanism of action is primarily attributed to its ability to disrupt the enzymatic activities within microbial cells. Nifuratel is believed to exert its effect by undergoing reduction within the target cells, leading to the formation of reactive intermediates. These intermediates then interact with cellular components such as DNA, proteins, and respiratory enzymes, inducing structural damage and inhibiting critical metabolic pathways. Particularly, the interaction with DNA is believed to involve the modification of nucleic acids, which disrupts DNA synthesis and leads to cell death. In research contexts, nifuratel has been employed in studies exploring the efficacy of antimicrobial agents against a spectrum of organisms, especially those resistant to common treatments. It serves as a model compound in the study of nitrofuran-based antimicrobial activity, providing insights into the mechanisms by which such compounds can overcome resistance. Additionally, research involving nifuratel has contributed to understanding the metabolic pathways of microbial resistance and adaptation, aiding in the development of strategies to counteract microbial proliferation in various environmental contexts. This has implications for improving sanitation and combating microbial contamination in diverse settings.


Nifuratel (CAS 4936-47-4) References

  1. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.  |  Korner, B. and Jensen, HK. 1976. Br J Vener Dis. 52: 404-8. PMID: 1087577
  2. Determination of nifuratel in human plasma by HPLC and study on its pharmacokinetics.  |  Wu, Y., et al. 2005. J Chromatogr Sci. 43: 179-82. PMID: 15975233
  3. An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies.  |  Li, XL., et al. 2007. Eur J Drug Metab Pharmacokinet. 32: 69-73. PMID: 17702193
  4. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?  |  Togni, G., et al. 2011. Antimicrob Agents Chemother. 55: 2490-2. PMID: 21321147
  5. Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition.  |  Zheng, H., et al. 2020. Colloids Surf B Biointerfaces. 193: 111109. PMID: 32416521
  6. Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses.  |  Lee, JE., et al. 2023. Int J Immunopathol Pharmacol. 37: 3946320231202349. PMID: 37706235
  7. Comparative in vitro activity of five nitrofurans.  |  Hamilton-Miller, JM. and Brumfitt, W. 1978. Chemotherapy. 24: 161-5. PMID: 657876

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Nifuratel, 10 mg

sc-219375
10 mg
$300.00